<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">0375400</journal-id><journal-id journal-id-type="pubmed-jr-id">4942</journal-id><journal-id journal-id-type="nlm-ta">J Med Entomol</journal-id><journal-id journal-id-type="iso-abbrev">J Med Entomol</journal-id><journal-title-group><journal-title>Journal of medical entomology</journal-title></journal-title-group><issn pub-type="ppub">0022-2585</issn><issn pub-type="epub">1938-2928</issn></journal-meta><article-meta><article-id pub-id-type="pmid">39425905</article-id><article-id pub-id-type="pmc">11808927</article-id><article-id pub-id-type="doi">10.1093/jme/tjae130</article-id><article-id pub-id-type="manuscript">HHSPA2050953</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A scoping review to determine if adverse human health effects are associated with use of organophosphates for mosquito control</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tai</surname><given-names>Zoe</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Connelly</surname><given-names>C. Roxanne</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Lange</surname><given-names>Suzanne Kuczynski</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0268-1570</contrib-id><name><surname>Foley</surname><given-names>Nicole</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>De Leon Rivera</surname><given-names>Juan</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1517-6853</contrib-id><name><surname>Lozano</surname><given-names>Saul</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1447-398X</contrib-id><name><surname>Nett</surname><given-names>Randall J.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA</aff><aff id="A2"><label>2</label>Colorado School of Public Health, Colorado State University, Fort Collins, CO, USA</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Author contributions</p><p id="P2">Zoe Tai (Data curation [equal], Formal analysis [equal], Investigation [equal], Writing&#x02014;original draft [equal], Writing&#x02014;review &#x00026; editing [equal]), Roxanne Connelly (Conceptualization [equal], Data curation [equal], Formal analysis [equal], Investigation [equal], Methodology [equal], Project administration [equal], Supervision [equal], Writing&#x02014;original draft [equal], Writing&#x02014;review &#x00026; editing [equal]), Suzanne Kuczynski Lange (Data curation [equal], Formal analysis [equal], Investigation [equal], Writing&#x02014;original draft [Equal], Writing&#x02014;review &#x00026; editing [equal]), Nicole Foley (Data curation [equal], Writing&#x02014;original draft [equal], Writing&#x02014;review &#x00026; editing [equal]), Juan De Leon Rivera (Data curation [equal], Writing&#x02014;review &#x00026; editing [equal]), Saul Lozano Fuentes (Formal analysis [equal], Writing&#x02014;original draft [equal], Writing&#x02014;review &#x00026; editing [equal]), and Randall Nett (Conceptualization [equal], Data curation [equal], Formal analysis [equal], Investigation [equal], Methodology [equal], Project administration [equal], Software [equal], Supervision [equal], Writing&#x02014;original draft [equal], Writing&#x02014;review &#x00026; editing [equal])</p></fn><corresp id="CR1"><label>*</label>Corresponding author, <email>gge5@cdc.gov</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>3</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="ppub"><day>13</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>2</month><year>2025</year></pub-date><volume>62</volume><issue>1</issue><fpage>8</fpage><lpage>18</lpage><abstract id="ABS1"><p id="P3">Organophosphate insecticides are widely used for adult mosquito control. Although proven effective in reducing mosquito populations and limiting arbovirus transmission, public concern exists regarding potential human health effects associated with organophosphate exposure. The aim of this scoping review was to describe any reported human health conditions associated with organophosphates during their use for adult mosquito control in the United States and Canada. Original peer-reviewed articles published in English language journals from 1 January 2000 to 22 May 2024, were obtained by searching from the databases MEDLINE, EMBASE, Agricultural &#x00026; Environmental Science Collection, CAB Abstracts, and Scopus. The search identified 6,154 screened articles. Following an independent review, 10 studies were identified that described human health conditions associated with organophosphate exposure during adult mosquito control applications. Of the 10 included studies, only two articles were published within the last 11 years (2013 to 22 May 2024). Three types of study design were represented in the included studies: cohort (<italic toggle="yes">n</italic> = 5), case study (<italic toggle="yes">n</italic> = 1), and risk assessment (<italic toggle="yes">n</italic> = 4). The included studies could not determine causality between exposure to adulticides and development of illness or adverse impacts. Exposure to organophosphates did not contribute to an observed increase in metabolic toxicity, hospitalization rates, or self-reported symptoms and exposure. The available and limited evidence indicates that organophosphates can be used safely to control nuisance mosquitoes or mosquitoes that transmit arboviruses. Continued research regarding the human health effects associated with organophosphate applications for adult mosquito control could help evaluate the basis of the public&#x02019;s concerns and inform public health decision-making.</p></abstract><kwd-group><kwd>adulticide</kwd><kwd>ultra-low volume</kwd><kwd>malathion</kwd><kwd>naled</kwd><kwd>integrated mosquito management</kwd></kwd-group></article-meta></front><body><sec id="S1"><title>Introduction</title><p id="P4">The organophosphate class of insecticides (e.g., malathion, naled) have been used for decades and are registered by the Environmental Protection Agency (EPA) and commonly used for adult mosquito control in the United States (<xref rid="R12" ref-type="bibr">Centers for Disease Control and Prevention 2023b</xref>, <xref rid="R17" ref-type="bibr">Environmental Protection Agency 2023a</xref>). Organophosphates cause mosquito death by inactivating acetylcholinesterase, which in turn leads to accumulation of acetylcholine, neurological dysfunction, and subsequent death (<xref rid="R20" ref-type="bibr">Fukuto 1990</xref>, <xref rid="R12" ref-type="bibr">Centers for Disease Control and Prevention 2023b</xref>, <xref rid="R34" ref-type="bibr">Robb and Baker 2023</xref>). In humans, organophosphate toxicity is well-documented and associated with increased saliva and tear production, diarrhea, nausea, vomiting, sweating, muscle tremors, and confusion. However, symptoms associated with organophosphate human toxicity occur following substantially higher exposure levels compared with doses used for typical mosquito control (<xref rid="R25" ref-type="bibr">Institute of Medicine (US) Committee on Health Effects Associated with Exposures During the Gulf War 2000</xref>, <xref rid="R28" ref-type="bibr">Mendes et al. 2018</xref>, <xref rid="R13" ref-type="bibr">Chen et al. 2019</xref>, <xref rid="R1" ref-type="bibr">Aroniadou-Anderjaska et al. 2020</xref>).</p><p id="P5">During arboviral disease outbreaks, the most efficient and effective way to limit the number of mosquitoes that can spread viruses is through the application of adulticides, such as organophosphates (<xref rid="R6" ref-type="bibr">Bonds 2012</xref>, <xref rid="R10" ref-type="bibr">Centers for Disease Control and Prevention 2020</xref>, <xref rid="R16" ref-type="bibr">Environmental Protection Agency 2022</xref>). In the United States, EPA-registered adulticides are typically applied through ground or aerial ultra-low volume (ULV) spraying whereby ULV diffusers aerosolize droplets of insecticide to kill flying mosquitoes on contact (<xref rid="R16" ref-type="bibr">Environmental Protection Agency 2022</xref>). The ULV applications of insecticides allow for large geographical coverage using the minimum effective volumes to reduce the resultant risks that adulticides can pose for human, animal, and environmental health (<xref rid="R6" ref-type="bibr">Bonds 2012</xref>, <xref rid="R16" ref-type="bibr">Environmental Protection Agency 2022</xref>). Although the amount of organophosphates applied nationally for adult mosquito control is not known, the use of organophosphates is likely somewhat common given that mosquito control programs often preferentially use pyrethroids, and 49% of mosquito control programs reported conducting both larviciding and adulticiding, and 3% reported conducting only adulticiding (<xref rid="R30" ref-type="bibr">National Association of County and City Health Officials 2017</xref>).</p><p id="P6">In the United States, multiple arboviruses can cause illness through endemic and travel-associated infections including eastern equine encephalitis, La Crosse, St. Louis encephalitis, West Nile, dengue, and Zika viruses (<xref rid="R4" ref-type="bibr">Beckham and Tyler 2015</xref>, <xref rid="R19" ref-type="bibr">Fagre et al. 2023</xref>). Most notably, West Nile virus (WNV) is consistently the leading cause of domestically-acquired arboviral disease in the United States with over 56,500 human cases and 2,700 deaths reported since its introduction in 1999 (<xref rid="R11" ref-type="bibr">Centers for Disease Control and Prevention 2023a</xref>). Modern-day advancements in global transportation systems, arthropod adaptation to urban environments, viral mutations, land perturbation, and climate change have contributed to the widespread and rapid emergence of arboviruses (<xref rid="R26" ref-type="bibr">Liang et al. 2015</xref>, <xref rid="R22" ref-type="bibr">Gould et al. 2017</xref>). In addition, the lack of vaccines or therapeutics for the majority of arboviral diseases including WNV disease (<xref rid="R23" ref-type="bibr">Gould et al. 2023</xref>), and the limited adherence to personal protective measures (<xref rid="R24" ref-type="bibr">Haenchen et al. 2016</xref>), makes effective mosquito control a critical tool to prevent arboviral diseases.</p><p id="P7">The rise in arboviral disease outbreaks has led to increased ground and aerial applications in regions that previously did not require mosquito control (19). Additionally, control measures in areas known for high mosquito populations have also intensified (<xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>). The practice and increased use of adulticide spraying have raised concerns among the public about the safety and risks of insecticide use (<xref rid="R33" ref-type="bibr">Rampold et al. 2020</xref>). The purpose of this review was to describe the currently available evidence of any reported adverse human health effects associated with organophosphates applied for adult mosquito control. By summarizing any potential health effects associated with organophosphate adulticide exposure, steps can be taken to mitigate potential risk or perceived risk, inform the use of evidence-based mosquito control, and prompt future research directions and guidelines.</p></sec><sec id="S2"><title>Materials and Methods</title><sec id="S3"><title>PRISMA-ScR</title><p id="P8">Our scoping review was performed according to the PRISMA extension for scoping reviews (PRISMA-ScR) and accompanying checklist from <xref rid="R40" ref-type="bibr">Tricco et al. (2018)</xref>. In <xref rid="SD1" ref-type="supplementary-material">Supplementary Appendix 1</xref>, we provide a guide to which pages address the specified &#x0201c;reporting items&#x0201d; from the PRISMA-ScR checklist. The protocol for this review was registered with Open Science Framework (<ext-link xlink:href="10.17605/OSF.IO/H8JZQ" ext-link-type="doi">https://doi.org/10.17605/OSF.IO/H8JZQ</ext-link>).</p></sec><sec id="S4"><title>Search Strategy</title><p id="P9">Original peer-reviewed articles published in English language journals from 1 January 2000 to 22 May 2024, were obtained through a comprehensive literature search from the bibliographic databases MEDLINE, EMBASE, Agricultural &#x00026; Environmental Science Collection, CAB Abstracts, and Scopus. The final search strategy for all databases can be found in <xref rid="SD2" ref-type="supplementary-material">Supplementary Appendix 2</xref>.</p></sec><sec id="S5"><title>Data Collection and Storage</title><p id="P10">All identified articles from the searches were transferred to screening and data extraction software (Covidence Systematic Review Software, Veritas Health Innovation, Melbourne, Australia), and duplicates were removed. The search of all databases yielded 6,154 potentially relevant articles.</p></sec><sec id="S6"><title>Identification of Relevant Studies</title><p id="P11">Eligible articles were screened for inclusion and exclusion criteria (<xref rid="T1" ref-type="table">Table 1</xref>). To be eligible for inclusion, the original peer-reviewed articles had to meet five criteria developed by authors CRC and RJN. First, studies needed to have been conducted in the United States or Canada. Mosquito control in other countries differs substantially in methodology in large part because of differing endemic mosquito species and lack of stringent regulations and guidelines concerning appropriate insecticide applications and were thus excluded (<xref rid="R7" ref-type="bibr">Carrasco et al. 2019</xref>, <xref rid="R21" ref-type="bibr">Gorris et al. 2021</xref>). Second, this review aims to classify exposure to specific insecticides used for adult mosquito control. Studies involving insecticides other than organophosphates (e.g., pyrethroids) were excluded. Articles that examined exposure to multiple insecticides that also included organophosphates were included, but only data related to organophosphate exposure were included. Third, studies that examined insecticide exposure via routes other than ground or aerial spraying (e.g., bed nets, indoor spraying, indoor coils) were excluded given these methods are not typically used for adult mosquito control in the United States or Canada. Fourth, studies needed to report a human health effect associated with exposure to select insecticides. Studies conducted in vitro and animal studies were excluded. Fifth, only peer-reviewed articles written in English were included. Nonsystematic and systematic review articles were included. Articles identified through the article screening process not included in the original literature search that also met inclusion criteria were included. Presentations, white papers, grey literature, abstracts, and trade articles were excluded.</p></sec><sec id="S7"><title>Selection of Relevant Studies</title><p id="P12">A team of six independent reviewers screened all relevant studies from the literature search for potential inclusion using Covidence software. In the first round of screening, a team of five independent reviewers (ZT, SKL, NF, JR, and RJN) assessed titles and abstracts of all included records using the predefined inclusion and exclusion criteria (<xref rid="T1" ref-type="table">Table 1</xref>). Each record was independently screened by random combinations of two reviewers and any discrepancies in eligibility were resolved by a third reviewer (CRC). The final round of screening included full-text review for inclusion and exclusion criteria using the same protocol described for title/abstract screening.</p></sec><sec id="S8"><title>Data Extraction from Included Studies</title><p id="P13">Data were extracted for selected articles and included the following: characteristics (e.g., title, date of publication, citation information, DOI), class of insecticide (e.g., organophosphate or pyrethrins/synthetic pyrethroids), setting characteristics (e.g., distribution methods, location, temperature, and weather conditions), methodology (e.g., type of study performed, aim of study, duration of study), participant information (e.g., population description, recruitment method, age, sex, comorbidities, subgroups), outcomes (e.g., outcome description, diagnostic criteria of outcome, risk estimates, power, sample size), data analysis, and key conclusions.</p></sec></sec><sec id="S9"><title>Results</title><sec id="S10"><title>Identification of Potential Studies</title><p id="P14">The searches from MEDLINE, EMBASE, Agricultural &#x00026; Environmental Science Collection, CAB Abstracts, and Scopus databases, yielded 6,154 articles that led to screening of 6,125 titles and abstracts after the removal of duplicates (<xref rid="F1" ref-type="fig">Fig. 1</xref>). A total of 44 articles were identified for full-text screening. Twenty articles were identified as relevant. Of these, 11 articles were excluded because they lacked mention of organophosphates. An additional reference was identified from the reference list of an article during full-text review. Ultimately, a total of 10 articles were included in this scoping review (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>, <xref rid="R9" ref-type="bibr">2005</xref>, <xref rid="R31" ref-type="bibr">O&#x02019;Sullivan et al. 2005</xref>, <xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>, <xref rid="R35" ref-type="bibr">Scharf et al. 2008</xref>, <xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>, <xref rid="R37" ref-type="bibr">2015</xref>, <xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>).</p></sec><sec id="S11"><title>Characteristics of the Included Studies</title><p id="P15">Of the 10 included studies, only two articles were published within the last 11 years (1 January 2013&#x02013;22 May 2024) (<xref rid="R37" ref-type="bibr">Schleier et al. 2015</xref>, <xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>), and eight were published from 2000 to 2012 (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>, <xref rid="R9" ref-type="bibr">2005</xref>, <xref rid="R31" ref-type="bibr">O&#x02019;Sullivan et al. 2005</xref>, <xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>, <xref rid="R35" ref-type="bibr">Scharf et al. 2008</xref>, <xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>).</p><p id="P16">The majority of analyzed studies were conducted within the United States (<italic toggle="yes">n</italic> = 9) (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>, <xref rid="R9" ref-type="bibr">2005</xref>, <xref rid="R31" ref-type="bibr">O&#x02019;Sullivan et al. 2005</xref>, <xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>, <xref rid="R35" ref-type="bibr">Scharf et al. 2008</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>, <xref rid="R37" ref-type="bibr">2015</xref>, <xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>); one study was conducted in Canada (<xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>). Of the studies conducted in the United States, data were included from Arizona, California, Florida, Louisiana, Michigan, New York, North Carolina, Oregon, Texas, Virginia, and Washington. Two separate studies reported data collected from multiple states (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>, <xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>). All other included studies only reported data from a single geographical location. Weather data from New York and Massachusetts were used for two risk assessment studies.</p></sec><sec id="S12"><title>Method of Insecticide Application and Insecticides Used</title><p id="P17">All included studies had defined methods of insecticide application: ground application, or aerial spraying by helicopter or airplane. The ULV spraying methods were specified in eight studies (<xref rid="R31" ref-type="bibr">O&#x02019;Sullivan et al. 2005</xref>, <xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>, <xref rid="R37" ref-type="bibr">2015</xref>); two studies did not specify ULV methods but conducted spraying events in accordance with insecticide labeling and regulations from the U.S. EPA and Health Canada Pest Management Regulatory Agency (PMRA) (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>, <xref rid="R35" ref-type="bibr">Scharf et al. 2008</xref>, <xref rid="R17" ref-type="bibr">Environmental Protection Agency 2023a</xref>). One study used absorption of aqueous malathion as a proxy to measure potential insecticide exposure from recreational swimming during aerial spraying (<xref rid="R35" ref-type="bibr">Scharf et al. 2008</xref>). Malathion and naled were used commonly for adult mosquito control and were mentioned in all included articles. Only two studies examined health effects associated with a single insecticide (e.g., either only malathion or only naled) (27, 31). The other eight studies examined insecticide exposures to a combination of malathion, naled, and other insecticides that were not organophosphates (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>, <xref rid="R9" ref-type="bibr">2005</xref>, <xref rid="R31" ref-type="bibr">O&#x02019;Sullivan et al. 2005</xref>, <xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>, <xref rid="R35" ref-type="bibr">Scharf et al. 2008</xref>, <xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>, <xref rid="R37" ref-type="bibr">2015</xref>, <xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>).</p></sec><sec id="S13"><title>Types of Methods and Design</title><p id="P18">Three types of study design were represented in the included studies: cohort (<italic toggle="yes">n</italic> = 5), case study (<italic toggle="yes">n</italic> = 1), and risk assessment (<italic toggle="yes">n</italic> = 4). The five cohort studies included both retrospective and prospective cohort studies.</p></sec><sec id="S14"><title>Cohort</title><p id="P19">In <xref rid="T2" ref-type="table">Table 2</xref>, we summarize five articles describing the cohort studies evaluating human health effects as an outcome of organophosphate insecticide exposure (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>, <xref rid="R9" ref-type="bibr">2005</xref>, <xref rid="R31" ref-type="bibr">O&#x02019;Sullivan et al. 2005</xref>, <xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>, <xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>). Two studies were retrospective investigations that examined the severity of insecticide-related illness and injury and hospitalizations associated with asthma exacerbation following insecticide exposure (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>, <xref rid="R31" ref-type="bibr">O&#x02019;Sullivan et al. 2005</xref>). One cohort monitored exposure calls and emergency department (ED) visits associated with insecticide exposure before and after a spray event in 2016 (<xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>). This study also compared historical data with data collected during the 2016 spray event for ED visits for asthma, reactive airway disease, wheezing, or shortness of breath. Two prospective cohort studies assessed urine levels of a nonspecific organophosphate metabolite, dimethyl phosphate (DMP), before and after a spray event (31, 32). Participants of each of the cohort studies, except for Duprey et al. and Centers for Disease Control and Prevention (CDC), were recruited through hospitalization records, poison information call center records, or state-based surveillance of acute insecticide-related illness and injury cases that matched residential zip codes with spray events (<xref rid="R9" ref-type="bibr">Centers for Disease Control and Prevention 2005</xref>, <xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>). Duprey et al. recruited participants through random households chosen within each proposed spray zone based on sample clustering (<xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>). The CDC study published in 2005 recruited individuals randomly chosen within census blocks marked for spraying (<xref rid="R9" ref-type="bibr">Centers for Disease Control and Prevention 2005</xref>). All participants in each of the cohort studies were living in residential areas exposed to spray events and ranged in age and sex from adult females (aged 18&#x02013;76 years), adult males (18&#x02013;76 years), youth (10&#x02013;12 years), children (5&#x02013;6 years), toddlers (2&#x02013;3 years), and infants (0.5&#x02013;1.5 years). No data were reported for children aged 1.5&#x02013;2 years.</p></sec><sec id="S15"><title>Case Study</title><p id="P20">In <xref rid="T3" ref-type="table">Table 3</xref> we summarize the single case study. Scharf et al. examined the dermal absorption rate of malathion and conducted a simulation experiment to determine the potential health impact on recreational swimmers exposed to waters following a malathion application (<xref rid="R35" ref-type="bibr">Scharf et al. 2008</xref>). In this study, 20 volunteers (<italic toggle="yes">n</italic> = 2 female, <italic toggle="yes">n</italic> = 18 male) aged 25&#x02013;50 years had dermal exposure to aqueous malathion and absorption rates were compared to a hazard index (HI). This study was used to extrapolate information to determine theoretical insecticide values that recreational swimmers might be exposed to after an aerial spraying event. In this single study, exposure to aqueous malathion in concentrations that could be expected during recreational swimming following an aerial spray event did not result in substantial dermal absorption in simulated test subjects.</p></sec><sec id="S16"><title>Risk Assessment</title><p id="P21">In <xref rid="T4" ref-type="table">Table 4</xref> we summarize four risk assessment studies (<xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>, <xref rid="R37" ref-type="bibr">2015</xref>). Toxicological risk is often expressed as risk quotients (RQ), which are determined through simulated environmental concentrations, exposure routes, and known toxicity endpoints; RQ values below 1.0 signify levels not warranting regulatory concern (<xref rid="R18" ref-type="bibr">Environmental Protection Agency 2023b</xref>). The exposure pathways range from acute to subchronic exposures, encompassing various scenarios such as inhalation, dermal exposure from spray deposition, hand-to-mouth exposure, and ingestion of garden produce, among others.</p><p id="P22">The four referenced studies assess risk to human health linked to insecticide use in mosquito control, focusing on different exposure routes and demographics (<xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>, <xref rid="R37" ref-type="bibr">2015</xref>). They employed Bayesian inference for RQ determination relating to health effects from organophosphate exposure. Setting it apart, the study presented in <xref rid="R37" ref-type="bibr">Schleier et al. 2015</xref> is a meta-analysis that includes data from the other three studies (<xref rid="R37" ref-type="bibr">Schleier et al. 2015</xref>). <xref rid="R37" ref-type="bibr">Schleier et al. 2015</xref> revised an earlier RQ estimation for adult males exposed to malathion from 0.02 to 0.41, integrating new insights from additional studies (<xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>, <xref rid="R37" ref-type="bibr">2015</xref>).</p><p id="P23">The remaining three studies covered more than one insecticide but included malathion and naled. The studies analyzed exposure from both ground or aerial in silico ULV spraying, using the AERMOD/ISCST3 or AGDISP models that assessed for the potential of drift under specified atmospheric and operating conditions (<xref rid="R5" ref-type="bibr">Bilanin AJ et al. 1989</xref>, <xref rid="R39" ref-type="bibr">Teske ME et al. 2019</xref>), and assessed the risk across a range of ages (<xref rid="T4" ref-type="table">Table 4</xref>) (<xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>). Assumptions made for the ULV simulations and risk estimates were broadly comparable and included: (i) all chemicals had a 24-h half-life in air; (ii) naled had an 18-h half-life; (iii) insecticides were applied at maximum application rates; and (iv) all insecticides were subject to the same weather conditions with no weather stress during the spray event.</p><p id="P24">Peterson et al. (19) indicated that aerial applications resulted in significantly lower deposition levels, denoting reduced human exposure and risk (<xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>). This contrasts with <xref rid="R41" ref-type="bibr">Valcke et al. (2008)</xref>, who found increased risks with aerial spraying, likely due to increased application rates (<xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>). Notably, Peterson et al. did not publish their findings on aerial ULV (<xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>). The low risk assessed from aerial spraying found by Peterson is likely the reason why <xref rid="R36" ref-type="bibr">Schleier et al. (2009)</xref> only evaluated ground ULV risk.</p><p id="P25">Contrasting ground applications, Peterson and Valcke reported significantly different acute air concentrations at similar application rates (9.76 &#x003bc;g/m<sup>3</sup> vs. 159.6 &#x003bc;g/m<sup>3</sup> for 61 g/ha and 63 g/ha, respectively) (<xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>). This difference in air concentrations likely influenced RQs values, although final risk assessment requires consideration of more factors than application rates.</p><p id="P26">In <xref rid="F2" ref-type="fig">Fig. 2</xref> some reported RQ values for each population subgroup and exposure routes are outlined for the included studies. With the exception of acute and subchronic aerial exposure for infants and toddlers reported in <xref rid="R41" ref-type="bibr">Valcke et al. (2008)</xref>, all other reported RQ&#x02019;s were less than 1.0 (<xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>, <xref rid="R37" ref-type="bibr">2015</xref>). The RQ values &#x0003e;1.0 may indicate possible adverse health effects. Unfortunately, methodological differences (19, 24, 25, 26) make direct comparison among the studies challenging. Furthermore, age is used as a proxy for body weight and exposure behaviors, and the age categories (infant, toddler, etc.) are not the same.</p></sec><sec id="S17"><title>Characteristics of Health-Related Effects Assessed by Included Studies</title><sec id="S18"><title>Poison Control Center and State-Based Insecticide Poisoning Surveillance Programs</title><p id="P27">Of the included studies, one article examined insecticide exposure through monitoring calls to poison information centers (<xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>). Likos et al. reported in the periods after ULV naled spraying events, a total of seven self-reported exposure calls were reported to the Florida Poison Information Center (<xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>). Four of these calls included reports of symptoms such as vomiting, eye irritation, dizziness, vertigo, and edema. No data were reported that compared the number of poison control center calls before ULV spraying events or following other historical ULV sprayings. Given the lack of systematic data surrounding these self-reports, it is difficult to draw meaningful conclusions.</p><p id="P28">Another study identified 133 cases of acute insecticide-related illness potentially associated with mosquito control through state-based insecticide poisoning surveillance programs (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>). Of the total mosquito-control insecticide-related illness cases identified, malathion and naled contributed to 48.1% and 17.3% of total cases, respectively. This study further classified the identified cases on a severity index in which malathion and naled cases were associated with illnesses of moderate to low severity. The cases reported in this study were associated with respiratory, neurological, gastrointestinal, ocular, dermal, cardiovascular, renal-genitourinary, and other miscellaneous illnesses.</p></sec><sec id="S19"><title>ED Visits/Hospitalizations</title><p id="P29">ED visits and hospitalizations were reported in two included studies (<xref rid="R31" ref-type="bibr">O&#x02019;Sullivan et al. 2005</xref>, <xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>). The ED visits and hospitalizations for acute asthma exacerbation, reactive airway disease, wheezing, and shortness of breath were recorded for duration of spray events and compared with previous years&#x02019; data. Likos et al. reported that ED visits were unchanged from the number of visits before spraying (<xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>). Data comparison from the previous two years revealed the percentage of ED visits for the four conditions or symptoms (asthma exacerbation, reactive airway disease, wheezing, and shortness of breath) were similar on a week-by-week basis. O&#x02019;Sullivan et al. specifically reported ED visits caused by acute asthma exacerbation for pediatric and adult visits (<xref rid="R31" ref-type="bibr">O&#x02019;Sullivan et al. 2005</xref>). There were no significant differences in admission rates for asthma per day on the dates prior to and following a spray event compared with the average asthma admission rate for either adult or pediatric cases.</p></sec><sec id="S20"><title>DMP/Absorption Values</title><p id="P30">DMP is a product of metabolized organophosphates and is readily excreted in urine within a few days of exposure (<xref rid="R3" ref-type="bibr">Barr et al. 2004</xref>). DMP indicates exposure to organophosphates; however, the correlation between measurable DMP values and potential adverse health effects remains unexplored (<xref rid="R3" ref-type="bibr">Barr et al. 2004</xref>). Duprey et al. reported no increases in urinary DMP in urine samples collected after spray events compared with samples collected before spray events (<xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>). In this analysis, some participants reported several non-specific health-related symptoms that included nausea, vomiting, diarrhea, abdominal cramps, headaches, and trembling, but symptoms were more often reported before spraying than after. Notably, some participants engaged in activities that could contribute to increases in urinary DMP (i.e., applying flea and tick prevention treatments on pets or the lawn); however, these activities were more often reported before spraying occurred than after. Most urine samples collected were below the limit of detection (LOD) of 0.5 micrograms/L. Only the final collection period following the last spray event produced a median level of DMP of 1.85 micrograms/L, substantially below the 95<sup>th</sup> percentile of background level DMP of 13 micrograms/L (<xref rid="R3" ref-type="bibr">Barr et al. 2004</xref>).</p><p id="P31">Results from a CDC report published in 2005, also found no significant increases in urinary DMP in urine samples after ULV insecticide sprayings in North Carolina and Virginia in 2003 (<xref rid="R9" ref-type="bibr">Centers for Disease Control and Prevention 2005</xref>). In the North Carolina cohort, participants were exposed to ULV naled and permethrin. DMP was detected in 46% of prespray urine samples and 49% of postspray samples in North Carolina (LOD = 0.5 micrograms/L). In Virginia, participants were exposed to ULV naled and d-phenothrin and DMP was detected in 42% of prespray samples and 48% in postspray samples (LOD = 0.5 micrograms/L).</p><p id="P32">Absorption of aqueous malathion was also examined as a possible route of exposure and health effect associated with adult mosquito control. Scharf et al. measured skin dosage of malathion absorbed and derived permeability across skin (Kp-malathion) values among volunteers experimentally exposed to aqueous malathion (<xref rid="R35" ref-type="bibr">Scharf et al. 2008</xref>). The study reported the mean Kp-malathion values were 0.0005 L/cm<sup>2</sup>/h (range: 0.0&#x02013;0.0051 L/cm<sup>2</sup>/h). Using Kp-values, HI values were extrapolated for theoretical 3-h swimming pool exposure to 30 ppb malathion + 30 ppb malaoxon. Malaoxon is the oxidized form of malathion when dissolved in bodies of water (<xref rid="R35" ref-type="bibr">Scharf et al. 2008</xref>). The HI model assumes participants absorbed all malathion in the exposure tank (12 &#x003bc;g/kg/day) and is compared to the Reference Exposure Level for malathion (200 &#x003bc;g/kg/day) for an HI of 0.6. The mean theoretically derived HI value for adult swimmers was 0.21 and for a child swimmer was 0.29. This laboratory-simulated experiment revealed that aqueous malathion resulting from aerial ULV spraying events would not be appreciably absorbed and did not meet levels of regulatory concern.</p></sec></sec></sec><sec id="S21"><title>Discussion</title><p id="P33">This scoping review used standard systematic review methods to identify, select, and synthesize findings from 10 studies that reported health effects associated with organophosphates used for adult mosquito control in the United States and Canada (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>, <xref rid="R9" ref-type="bibr">2005</xref>, <xref rid="R31" ref-type="bibr">O&#x02019;Sullivan et al. 2005</xref>, <xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>, <xref rid="R35" ref-type="bibr">Scharf et al. 2008</xref>, <xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>, <xref rid="R37" ref-type="bibr">2015</xref>, <xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>). We documented the current state of published literature that assessed health effects associated with organophosphates applied for adult mosquito control by describing the methodology of insecticide applications, quantification and severity of exposure, and key findings. The results of this review identified evidence from 10 publications that when taken together indicated organophosphates used for mosquito adulticiding do not contribute substantially to increased metabolic toxicity in humans, increases in self-reported symptoms or conditions, hospitalization rates, or known risk to human health (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>, <xref rid="R9" ref-type="bibr">2005</xref>, <xref rid="R31" ref-type="bibr">O&#x02019;Sullivan et al. 2005</xref>, <xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>, <xref rid="R35" ref-type="bibr">Scharf et al. 2008</xref>, <xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>, <xref rid="R37" ref-type="bibr">2015</xref>, <xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>). These conclusions are consistent with those from a contemporaneously published systematic review article that assessed the human health effects with the organophosphate naled and its major degrade dichlorvos (<xref rid="R29" ref-type="bibr">Mendoza et al. 2023</xref>). Although this review article included four of the same studies as in our scoping review (<xref rid="R9" ref-type="bibr">Centers for Disease Control and Prevention 2005</xref>, <xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>), it differed by also including studies involving occupational exposures, private pesticide applicator exposure, agricultural pesticide applicator exposure, and ingestion of pesticides through foods.</p><p id="P34">The resulting search and screening of peer-reviewed articles from the past 23 years only yielded 10 relevant studies, with most studies conducted before 2010 (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>, <xref rid="R9" ref-type="bibr">2005</xref>, <xref rid="R31" ref-type="bibr">O&#x02019;Sullivan et al. 2005</xref>, <xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>, <xref rid="R35" ref-type="bibr">Scharf et al. 2008</xref>, <xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>, <xref rid="R37" ref-type="bibr">2015</xref>, <xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>). Many of the included studies were published around times of arboviral disease outbreaks. It is possible that more attention is given by the general public and researchers to adulticide applications and their potential health effects during times of outbreak control compared with adulticide applications for other intentions, like arboviral disease prevention or nuisance mosquito control. Because of the limited number and scope of the included studies, additional research with stronger study designs could help further elucidate any potential relationships between insecticide exposure and health effects. Planning robust studies well in advance of future adulticide applications that can be implemented on short notice will be important to provide additional and more definitive evidence about health effects in the general population following adulticide applications.</p><p id="P35">Two routes of metabolic toxicity were measured within the included studies (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>, <xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>, <xref rid="R35" ref-type="bibr">Scharf et al. 2008</xref>). Urinary DMP and dermal absorption of malathion data were analyzed. No significant increases to DMP levels occurred following organophosphate spray events and dermal absorption of malathion in a laboratory setting were below relevant reference exposure levels of concern. Although these two indicators of organophosphate exposure can be helpful, these measurements cannot be broadly applied to the various human exposure routes following insecticide spray events. Continued research into methods that quantify insecticide exposure through noninvasive sampling in various populations would provide additional understanding of human exposures to organophosphates during wide-area use of adulticides.</p><p id="P36">Data describing persons who report symptoms to call centers and poison control centers is useful for assessing potential health effects following specific spray events. Cases of illness identified through insecticide exposure surveillance programs identified respiratory, neurological, and gastrointestinal illnesses potentially associated with insecticide exposure (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>, <xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>). The CDC report in 2003 classified cases suspected or linked to malathion or naled exposure to have moderate to low severity (<xref rid="R8" ref-type="bibr">Centers for Disease Control and Prevention 2003</xref>). Although case studies can be helpful, exposure data can be affected by recall or reporting biases, for instance awareness of mosquito control applications could influence healthcare-seeking behaviors. This was illustrated by studies that did not observe significant differences in the number of calls after organophosphate spraying events compared with before the events (<xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>). Development of robust surveillance systems that includes pre-event monitoring could be implemented to detect potential illnesses associated with spray events and could help improve understanding of the relationship between any health effects and adulticide exposures.</p><p id="P37">ED and hospitalization rates for asthma and reactive airway disease did not change significantly before, during, or after organophosphate spray events (<xref rid="R31" ref-type="bibr">O&#x02019;Sullivan et al. 2005</xref>, <xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>). While the included studies were limited to cases related to asthma and reactive airway disease, notably other respiratory, dermal, neurological, gastrointestinal, and other illness types have been reported to be associated with high levels of organophosphate exposure (<xref rid="R34" ref-type="bibr">Robb and Baker 2023</xref>). These reported toxicological responses to organophosphate exposure far exceed the levels used in EPA-approved ULV spraying events (<xref rid="R6" ref-type="bibr">Bonds 2012</xref>, <xref rid="R16" ref-type="bibr">Environmental Protection Agency 2022</xref>, <xref rid="R34" ref-type="bibr">Robb and Baker 2023</xref>). The ED cases identified by O&#x02019;Sullivan et al. and Likos et al. would not have detected persons who suffered illness but did not seek care or those who visited outpatient clinics but were not transferred to the ED or hospitalized. In addition, exposures from household or occupational use of insecticides during times of high mosquito activity could contribute to human illnesses that make assessing illnesses caused by public health use of adulticides challenging. Duprey et al. reported in a household survey conducted before and after a spray event, 18.2% of respondents reported handling pesticides before spraying compared with 8.4% after spraying (<xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>). Further research is needed to determine if hospitalization data for illness and injury associated with insecticide exposure can be further characterized by home use or environmental exposures to organophosphates.</p><p id="P38">In our study, which included four risk assessments, three reported RQs below levels of concern (<xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>, <xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>, <xref rid="R37" ref-type="bibr">2015</xref>). However, the study by Valcke et al. found RQs greater than 1.0 (<xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>); this was specifically for age categories in the 0 to 11 years range who were exposed to malathion following acute aerial spraying. RQs &#x0003e; 1.0 were also reported for subchronic exposures for age categories in the 0&#x02013;4 years range. The EPA made similar observations, but only for acute aerial exposure for children aged 1&#x02013;2 years; all exposures from ground applications are considered by the EPA to not pose a risk (<xref rid="R15" ref-type="bibr">Environmental Protection Agency 2016</xref>).</p><p id="P39">According to the EPA, for a child aged 1&#x02013;2 years to experience an exposure that would result in an RQ &#x0003e; 1.0, each of the following conditions must be met: (a) live in an area directly treated; (b) maximum labeled rate is applied (3 fluid ounce product/Acre) while using the largest droplet size and at the lowest application height (100 ft); (c) weather is calm and nothing hinders the deposition on the ground (e.g., trees); (d) residues deposited do not dissipate (despite known rapid dissipation); (e) on the day of treatment the child engages in rigorous play outside in the treated area resulting in high skin exposure and high rate of contact; and (f) aerial deposition of malathion on the ground should be greater than 0.46 &#x003bc;g/cm<sup>2</sup>. Notably, 0.46 &#x003bc;g/cm<sup>2</sup> is approximately one-half of the concentration used in the Valcke et al. aerial scenario (0.905 &#x003bc;g/cm<sup>2</sup>) (<xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>).</p><p id="P40">Notably, RQs for adults were modeled with age ranges that varied from 18 to 65 years. Within such a wide range in the age category, various levels of health and comorbidities could affect potential susceptibility to illness and injury caused by insecticide exposure. Further research on risks to populations such as children, elderly, and those with immunocompromising conditions, should be considered.</p><p id="P41">The potential morbidity, mortality, healthcare costs, and societal costs, caused by arboviral diseases should be considered when assessing the risk of potential health effects associated with adulticide spray events. For WNV, during 1999&#x02013;2022, 28,684 cases of WNV neuroinvasive disease and 2,641 WNV-related deaths were reported in the United States (<xref rid="R11" ref-type="bibr">Centers for Disease Control and Prevention 2023a</xref>). The estimated hospitalization costs for each WNV neuroinvasive disease case is over $142,000 (<xref rid="R38" ref-type="bibr">Snyder et al. 2021</xref>); this equates to an estimated cost of about $3.2 billion in hospitalization costs since 1999. These estimates do not account for productivity lost by the patient or their caretakers, or long-term costs related to disability (<xref rid="R2" ref-type="bibr">Barber et al. 2010</xref>). For adults, when considering health outcomes of WNV exposure versus insecticide exposure as part of community spraying, the likelihood for severe outcomes from WNV exposure is substantially greater than for insecticide exposure (<xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>). Considering available data regarding the human health impacts, WNV poses a substantially higher risk to human health than organophosphate use as part of integrated mosquito management.</p><sec id="S22"><title>Limitations</title><p id="P42">This analysis is subject to several limitations. First, considering that organophosphates are commonly used for vector control, we only identified 10 studies relating to exposure to organophosphates with reported human health effects. Within those 10 studies, only two organophosphates were represented, malathion and naled. Other organophosphates (i.e., chlorpyrifos) have historically been used; however, given changes in organophosphate manufacturing and subsequent use, malathion and naled are the organophosphates used predominately for adult mosquito control. Secondly, the studies included in this review could not determine causality between exposure to adulticides and development of illness. Insecticide exposure often occurs alongside exposure to other chemicals or environmental factors that can influence health outcomes. Failing to account for these potential confounding factors can obscure the true relationship between insecticides and health effects. Finally, we only considered published articles without assessing the existing evidence in grey literature and other sources. The nonconsideration of grey literature and other sources restricts our findings to what was reported by scientific journals and identified in this literature search and could possibly prevent analysis of relevant cases that were rejected for publication or reported in other forums.</p></sec></sec><sec id="S23"><title>Conclusion</title><p id="P43">In summary, this scoping review indicates that according to available and limited evidence, no clear association exists between organophosphates used for adult mosquito control applied according to EPA label instructions and human health risk. This review also highlights the need for developing guidance for assessing potential health effects following adult mosquito control in a community. Continued research regarding the human health effects of insecticide applications can help evaluate the basis of the public&#x02019;s concerns and provide meaningful insight to public health decision-making. Overall, the available evidence indicates that organophosphates can be used safely for adult mosquito control.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>Supplemental Appendix 1</label><media xlink:href="NIHMS2050953-supplement-Supplemental_Appendix_1.docx" id="d67e959" position="anchor"/></supplementary-material><supplementary-material id="SD2" position="float" content-type="local-data"><label>Supplemental Appendix 2</label><media xlink:href="NIHMS2050953-supplement-Supplemental_Appendix_2.docx" id="d67e962" position="anchor"/></supplementary-material></sec></body><back><ack id="S24"><title>Acknowledgments</title><p id="P44">We would like to thank Sarah Page for assistance in conducting the comprehensive literature search. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention.</p></ack><fn-group><fn id="FN2"><p id="P45">Supplementary data</p><p id="P46">Supplementary data are available at <italic toggle="yes">Journal of Medical Entomology</italic> online.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><mixed-citation publication-type="journal"><name><surname>Aroniadou-Anderjaska</surname><given-names>V</given-names></name>, <name><surname>Figueiredo</surname><given-names>TH</given-names></name>, <name><surname>Apland</surname><given-names>JP</given-names></name>, <etal/>
<year>2020</year>. <article-title>Targeting the glutamatergic system to counteract organophosphate poisoning: a novel therapeutic strategy</article-title>. <source>Neurobiol. Dis</source>. <volume>133</volume>:<fpage>104406</fpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2019.02.017</pub-id><pub-id pub-id-type="pmid">30798006</pub-id>
</mixed-citation></ref><ref id="R2"><mixed-citation publication-type="journal"><name><surname>Barber</surname><given-names>LM</given-names></name>, <name><surname>Schleier</surname><given-names>JJ</given-names><suffix>3rd</suffix></name>, <name><surname>Peterson</surname><given-names>RK</given-names></name>. <year>2010</year>. <article-title>Economic cost analysis of West Nile virus outbreak, Sacramento County, California, USA, 2005</article-title>. <source>Emerg. Infect. Dis</source>. <volume>16</volume>(<issue>3</issue>):<fpage>480</fpage>&#x02013;<lpage>486</lpage>. <pub-id pub-id-type="doi">10.3201/eid1603.090667</pub-id><pub-id pub-id-type="pmid">20202424</pub-id>
</mixed-citation></ref><ref id="R3"><mixed-citation publication-type="journal"><name><surname>Barr</surname><given-names>DB</given-names></name>, <name><surname>Bravo</surname><given-names>R</given-names></name>, <name><surname>Weerasekera</surname><given-names>G</given-names></name>, <etal/>
<year>2004</year>. <article-title>Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the U.S. population</article-title>. <source>Environ. Health Perspect</source>. <volume>112</volume>(<issue>2</issue>):<fpage>186</fpage>&#x02013;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.6503</pub-id><pub-id pub-id-type="pmid">14754573</pub-id>
</mixed-citation></ref><ref id="R4"><mixed-citation publication-type="journal"><name><surname>Beckham</surname><given-names>JD</given-names></name>, <name><surname>Tyler</surname><given-names>KL</given-names></name>. <year>2015</year>. <article-title>Arbovirus infections</article-title>. <source>Continuum (Minneap Minn) 21(6 Neuroinfectious Disease)</source>:<fpage>1599</fpage>&#x02013;<lpage>1611</lpage>. <pub-id pub-id-type="doi">10.1212/CON.0000000000000240</pub-id></mixed-citation></ref><ref id="R5"><mixed-citation publication-type="journal"><name><surname>Bilanin</surname><given-names>AJ</given-names></name>, <name><surname>Teske</surname><given-names>ME</given-names></name>, <name><surname>Barry</surname><given-names>JW</given-names></name>, <etal/>
<year>1989</year>. <article-title>AGDISP: the aircraft spray dispersion model, code development and experimental validation</article-title>. <source>Trans. ASAE</source>
<volume>32</volume>(<issue>1</issue>):<fpage>327</fpage>&#x02013;<lpage>0334</lpage>.</mixed-citation></ref><ref id="R6"><mixed-citation publication-type="journal"><name><surname>Bonds</surname><given-names>JA</given-names></name>. <year>2012</year>. <article-title>Ultra-low-volume space sprays in mosquito control: a critical review</article-title>. <source>Med. Vet. Entomol</source>. <volume>26</volume>(<issue>2</issue>):<fpage>121</fpage>&#x02013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2915.2011.00992.x</pub-id><pub-id pub-id-type="pmid">22235908</pub-id>
</mixed-citation></ref><ref id="R7"><mixed-citation publication-type="journal"><name><surname>Carrasco</surname><given-names>D</given-names></name>, <name><surname>Lefevre</surname><given-names>T</given-names></name>, <name><surname>Moiroux</surname><given-names>N</given-names></name>, <etal/>
<year>2019</year>. <article-title>Behavioural adaptations of mosquito vectors to insecticide control</article-title>. <source>Curr. Opin. Insect Sci</source>. <volume>34</volume>:<fpage>48</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.cois.2019.03.005</pub-id><pub-id pub-id-type="pmid">31247417</pub-id>
</mixed-citation></ref><ref id="R8"><mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention</collab>. <year>2003</year>. <article-title>Surveillance for acute insecticide-related illness associated with mosquito-control efforts&#x02014;nine states, 1999&#x02013;2002</article-title>. <source>Morb. Mortal. Wkly. Rep</source>. <volume>52</volume>(<issue>27</issue>):<fpage>629</fpage>&#x02013;<lpage>634</lpage>.</mixed-citation></ref><ref id="R9"><mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention</collab>. <year>2005</year>. <article-title>Human exposure to mosquito-control pesticides&#x02014;Mississippi, North Carolina, and Virginia, 2002 and 2003</article-title>. <source>Morb. Mortal. Wkly. Rep</source>. <volume>54</volume>(<issue>21</issue>):<fpage>529</fpage>&#x02013;<lpage>532</lpage>.</mixed-citation></ref><ref id="R10"><mixed-citation publication-type="webpage"><collab>Centers for Disease Control and Prevention</collab>. <year>2020</year>. <source>Aerial spraying</source> [<date-in-citation>accessed 2024 Jan 25</date-in-citation>]. <comment><ext-link xlink:href="https://www.cdc.gov/mosquitoes/mosquito-control/aerial-spraying.html#:~:text=Aerial%20spraying%20is%20used%20to%20control%20and" ext-link-type="uri">https://www.cdc.gov/mosquitoes/mosquito-control/aerial-spraying.html#:~:text=Aerial%20spraying%20is%20used%20to%20control%20and</ext-link>.</comment></mixed-citation></ref><ref id="R11"><mixed-citation publication-type="book"><collab>Centers for Disease Control and Prevention</collab>. <year>2023a</year>. <part-title>West Nile virus: historic data (1999&#x02013;2023)</part-title> [<date-in-citation>accessed 2024 Jan 25</date-in-citation>]. <source>Historic Data (1999&#x02013;2023) | West Nile Virus</source> | <publisher-name>CDC</publisher-name>.</mixed-citation></ref><ref id="R12"><mixed-citation publication-type="book"><collab>Centers for Disease Control and Prevention</collab>. <year>2023b</year>. <part-title>Mosquito control in a community</part-title> [<date-in-citation>accessed 2023 Sep 10</date-in-citation>]. <source>Mosquito Control in a Community | Mosquitoes</source> | <publisher-name>CDC</publisher-name>.</mixed-citation></ref><ref id="R13"><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>KX</given-names></name>, <name><surname>Zhou</surname><given-names>XH</given-names></name>, <name><surname>Sun</surname><given-names>CA</given-names></name>, <etal/>
<year>2019</year>. <article-title>Manifestations of and risk factors for acute myocardial injury after acute organophosphorus pesticide poisoning</article-title>. <source>Medicine (Baltim.)</source>
<volume>98</volume>(<issue>6</issue>):<fpage>e14371</fpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000014371</pub-id></mixed-citation></ref><ref id="R14"><mixed-citation publication-type="journal"><name><surname>Duprey</surname><given-names>Z</given-names></name>, <name><surname>Rivers</surname><given-names>S</given-names></name>, <name><surname>Luber</surname><given-names>G</given-names></name>, <etal/>
<year>2008</year>. <article-title>Community aerial mosquito control and naled exposure</article-title>. <source>J. Am. Mosq. Control Assoc</source>. <volume>24</volume>(<issue>1</issue>):<fpage>42</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.2987/5559.1</pub-id><pub-id pub-id-type="pmid">18437813</pub-id>
</mixed-citation></ref><ref id="R15"><mixed-citation publication-type="webpage"><collab>Environmental Protection Agency</collab>. <year>2016</year>. <article-title>Malathion aerial mosquito control application parameters</article-title>. <source>Letter to American Mosquito Control Association and their membership</source> [<date-in-citation>accessed 2024 Jan 25</date-in-citation>]. <comment><ext-link xlink:href="https://www.epa.gov/sites/default/files/2020-09/documents/naled_amca_final_letter_9_4_2020_v2.pdf" ext-link-type="uri">https://www.epa.gov/sites/default/files/2020-09/documents/naled_amca_final_letter_9_4_2020_v2.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R16"><mixed-citation publication-type="webpage"><collab>Environmental Protection Agency</collab>. <year>2022</year>. <source>Success in mosquito control: an integrated approach</source> [<date-in-citation>accessed 2024 Jan 25</date-in-citation>]. <comment><ext-link xlink:href="https://www.epa.gov/mosquitocontrol/success-mosquito-control-integrated-approach#:~:text=Remove%20Mosquito%20Habitats,-An%20important%20part&#x00026;text=Because%20mosquitoes%20need%20water%20for,container%20where%20mosquitoes%20can%20breed" ext-link-type="uri">https://www.epa.gov/mosquitocontrol/success-mosquito-control-integrated-approach#:~:text=Remove%20Mosquito%20Habitats,-An%20important%20part&#x00026;text=Because%20mosquitoes%20need%20water%20for,container%20where%20mosquitoes%20can%20breed</ext-link>.</comment></mixed-citation></ref><ref id="R17"><mixed-citation publication-type="webpage"><collab>Environmental Protection Agency</collab>. <year>2023a</year>. <source>Pesticides used to control adult mosquitoes</source> [<date-in-citation>accessed 2024 Jan 25</date-in-citation>]. <comment><ext-link xlink:href="https://www.epa.gov/mosquitocontrol/pesticides-used-control-adult-mosquitoes" ext-link-type="uri">https://www.epa.gov/mosquitocontrol/pesticides-used-control-adult-mosquitoes</ext-link>.</comment></mixed-citation></ref><ref id="R18"><mixed-citation publication-type="webpage"><collab>Environmental Protection Agency</collab>. <year>2023b</year>. <source>Technical overview of ecological risk assessment: risk characterization</source> [<date-in-citation>accessed 2024 Jan 25</date-in-citation>]. <comment><ext-link xlink:href="https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/technical-overview-ecological-risk-assessment-risk" ext-link-type="uri">https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/technical-overview-ecological-risk-assessment-risk</ext-link>.</comment></mixed-citation></ref><ref id="R19"><mixed-citation publication-type="journal"><name><surname>Fagre</surname><given-names>AC</given-names></name>, <name><surname>Lyons</surname><given-names>S</given-names></name>, <name><surname>Staples</surname><given-names>JE</given-names></name>, <etal/>
<year>2023</year>. <article-title>West Nile virus and other nationally notifiable arboviral diseases&#x02014;United States, 2021</article-title>. <source>MMWR Morb. Mortal. Wkly. Rep</source>. <volume>72</volume>(<issue>34</issue>):<fpage>901</fpage>&#x02013;<lpage>906</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.mm7234a1</pub-id><pub-id pub-id-type="pmid">37616182</pub-id>
</mixed-citation></ref><ref id="R20"><mixed-citation publication-type="journal"><name><surname>Fukuto</surname><given-names>TR</given-names></name>. <year>1990</year>. <article-title>Mechanism of action of organophosphorus and carbamate insecticides</article-title>. <source>Environ. Health Perspect</source>. <volume>87</volume>:<fpage>245</fpage>&#x02013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.9087245</pub-id><pub-id pub-id-type="pmid">2176588</pub-id>
</mixed-citation></ref><ref id="R21"><mixed-citation publication-type="journal"><name><surname>Gorris</surname><given-names>ME</given-names></name>, <name><surname>Bartlow</surname><given-names>AW</given-names></name>, <name><surname>Temple</surname><given-names>SD</given-names></name>, <etal/>
<year>2021</year>. <article-title>Updated distribution maps of predominant <italic toggle="yes">Culex</italic> mosquitoes across the Americas</article-title>. <source>Parasit. Vectors</source>
<volume>14</volume>(<issue>1</issue>):<fpage>547</fpage>. <pub-id pub-id-type="doi">10.1186/s13071-021-05051-3</pub-id><pub-id pub-id-type="pmid">34688314</pub-id>
</mixed-citation></ref><ref id="R22"><mixed-citation publication-type="journal"><name><surname>Gould</surname><given-names>E</given-names></name>, <name><surname>Pettersson</surname><given-names>J</given-names></name>, <name><surname>Higgs</surname><given-names>S</given-names></name>, <etal/>
<year>2017</year>. <article-title>Emerging arboviruses: why today?</article-title>
<source>One Health</source>
<volume>4</volume>:<fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.onehlt.2017.06.001</pub-id><pub-id pub-id-type="pmid">28785601</pub-id>
</mixed-citation></ref><ref id="R23"><mixed-citation publication-type="journal"><name><surname>Gould</surname><given-names>CV</given-names></name>, <name><surname>Staples</surname><given-names>JE</given-names></name>, <name><surname>Huang</surname><given-names>CY</given-names></name>, <etal/>
<year>2023</year>. <article-title>Combating West Nile virus disease&#x02014;time to revisit vaccination</article-title>. <source>N. Engl. J. Med</source>. <volume>388</volume>(<issue>18</issue>):<fpage>1633</fpage>&#x02013;<lpage>1636</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMp2301816</pub-id><pub-id pub-id-type="pmid">37125778</pub-id>
</mixed-citation></ref><ref id="R24"><mixed-citation publication-type="journal"><name><surname>Haenchen</surname><given-names>SD</given-names></name>, <name><surname>Hayden</surname><given-names>MH</given-names></name>, <name><surname>Dickinson</surname><given-names>KL</given-names></name>, <etal/>
<year>2016</year>. <article-title>Mosquito avoidance practices and knowledge of arboviral diseases in cities with differing recent history of disease</article-title>. <source>Am. J. Trop. Med. Hyg</source>. <volume>95</volume>(<issue>4</issue>):<fpage>945</fpage>&#x02013;<lpage>953</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.15-0732</pub-id><pub-id pub-id-type="pmid">27527634</pub-id>
</mixed-citation></ref><ref id="R25"><mixed-citation publication-type="book"><collab>Institute of Medicine (US) Committee on Health Effects Associated with Exposures During the Gulf War</collab>. <year>2000</year>. <part-title>E, Effects of long-term exposure to organophosphate pesticides in humans</part-title>. In: <name><surname>Fulco</surname><given-names>CE</given-names></name>, <name><surname>Liverman</surname><given-names>CT</given-names></name>, <name><surname>Sox</surname><given-names>HC</given-names></name>, editors. <source>Gulf War and Health</source>. <publisher-loc>Washington DC, USA</publisher-loc>: <publisher-name>The Institute of Medicine</publisher-name>.</mixed-citation></ref><ref id="R26"><mixed-citation publication-type="journal"><name><surname>Liang</surname><given-names>G</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>, <name><surname>Gould</surname><given-names>EA</given-names></name>. <year>2015</year>. <article-title>Factors responsible for the emergence of arboviruses; strategies, challenges and limitations for their control</article-title>. <source>Emerg. Microbes Infect</source>. <volume>4</volume>(<issue>3</issue>):<fpage>e18</fpage>. <pub-id pub-id-type="doi">10.1038/emi.2015.18</pub-id><pub-id pub-id-type="pmid">26038768</pub-id>
</mixed-citation></ref><ref id="R27"><mixed-citation publication-type="journal"><name><surname>Likos</surname><given-names>A</given-names></name>, <name><surname>Griffin</surname><given-names>I</given-names></name>, <name><surname>Bingham</surname><given-names>AM</given-names></name>, <etal/>
<year>2016</year>. <article-title>Local mosquito-borne transmission of Zika virus&#x02014;Miami-Dade and Broward counties, Florida, June&#x02013;August 2016</article-title>. <source>MMWR Morb. Mortal. Wkly. Rep</source>. <volume>65</volume>(<issue>38</issue>):<fpage>1032</fpage>&#x02013;<lpage>1038</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.mm6538e1</pub-id><pub-id pub-id-type="pmid">27684886</pub-id>
</mixed-citation></ref><ref id="R28"><mixed-citation publication-type="journal"><name><surname>Mendes</surname><given-names>PA</given-names></name>, <name><surname>Pereira</surname><given-names>TC</given-names></name>, <name><surname>Pina</surname><given-names>R</given-names></name>, <etal/>
<year>2018</year>. <article-title>Chlorpyrifos-induced delayed neurotoxicity with a rare presentation of flaccid quadriplegia: a diagnostic challenge</article-title>. <source>Eur. J. Case Rep. Intern. Med</source>. <volume>5</volume>(<issue>1</issue>):<fpage>000751</fpage>. <pub-id pub-id-type="doi">10.12890/2017_000751</pub-id><pub-id pub-id-type="pmid">30755975</pub-id>
</mixed-citation></ref><ref id="R29"><mixed-citation publication-type="journal"><name><surname>Mendoza</surname><given-names>DL</given-names></name>, <name><surname>Peterson</surname><given-names>RKD</given-names></name>, <name><surname>Bonds</surname><given-names>JAS</given-names></name>, <etal/>
<year>2023</year>. <article-title>Are adult mosquito control products (adulticides) harmful? A review of the potential human health impacts from exposure to naled and dichlorvos (DDVP)</article-title>. <source>Pollutants</source>
<volume>3</volume>(<issue>4</issue>):<fpage>603</fpage>&#x02013;<lpage>615</lpage>. <pub-id pub-id-type="doi">10.3390/pollutants3040039</pub-id></mixed-citation></ref><ref id="R30"><mixed-citation publication-type="other"><collab>National Association of County and City Health Officials</collab>. <year>2017</year>. <source>Mosquito control capabilities in the U.S. Washington D.C</source>.</mixed-citation></ref><ref id="R31"><mixed-citation publication-type="journal"><name><surname>O&#x02019;Sullivan</surname><given-names>BC</given-names></name>, <name><surname>Lafleur</surname><given-names>J</given-names></name>, <name><surname>Fridal</surname><given-names>K</given-names></name>, <etal/>
<year>2005</year>. <article-title>The effect of pesticide spraying on the rate and severity of ED asthma</article-title>. <source>Am. J. Emerg. Med</source>. <volume>23</volume>(<issue>4</issue>):<fpage>463</fpage>&#x02013;<lpage>467</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajem.2004.12.017</pub-id><pub-id pub-id-type="pmid">16032612</pub-id>
</mixed-citation></ref><ref id="R32"><mixed-citation publication-type="journal"><name><surname>Peterson</surname><given-names>RK</given-names></name>, <name><surname>Macedo</surname><given-names>PA</given-names></name>, <name><surname>Davis</surname><given-names>RS</given-names></name>. <year>2006</year>. <article-title>A human-health risk assessment for West Nile virus and insecticides used in mosquito management</article-title>. <source>Environ. Health Perspect</source>. <volume>114</volume>(<issue>3</issue>):<fpage>366</fpage>&#x02013;<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.8667</pub-id><pub-id pub-id-type="pmid">16507459</pub-id>
</mixed-citation></ref><ref id="R33"><mixed-citation publication-type="journal"><name><surname>Rampold</surname><given-names>S</given-names></name>, <name><surname>Telg</surname><given-names>R</given-names></name>, <name><surname>Poulin</surname><given-names>A</given-names></name>, <etal/>
<year>2020</year>. <article-title>Public perceptions of mosquitoes and mosquito control</article-title>. <source>UF/IFAS</source>
<volume>2020</volume>(<issue>3</issue>):<fpage>1</fpage>&#x02013;<lpage>3</lpage>.</mixed-citation></ref><ref id="R34"><mixed-citation publication-type="book"><name><surname>Robb</surname><given-names>EL</given-names></name>, <name><surname>Baker</surname><given-names>MB</given-names></name>. <year>2023</year>. <part-title>Organophosphate toxicity</part-title>. <source>StatPearls</source>. <publisher-loc>Treasure Island (FL)</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name>.</mixed-citation></ref><ref id="R35"><mixed-citation publication-type="journal"><name><surname>Scharf</surname><given-names>JE</given-names></name>, <name><surname>Johnson</surname><given-names>GT</given-names></name>, <name><surname>Harbison</surname><given-names>SC</given-names></name>, <etal/>
<year>2008</year>. <article-title>Dermal absorption of a dilute aqueous solution of Malathion</article-title>. <source>J. Emerg. Trauma Shock</source>
<volume>1</volume>(<issue>2</issue>):<fpage>70</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.4103/0974-2700.43182</pub-id><pub-id pub-id-type="pmid">19561983</pub-id>
</mixed-citation></ref><ref id="R36"><mixed-citation publication-type="journal"><name><surname>Schleier</surname><given-names>JJ</given-names><suffix>III</suffix></name>, <name><surname>Macedo</surname><given-names>PA</given-names></name>, <name><surname>Davis</surname><given-names>RS</given-names></name>, <etal/>
<year>2009</year>. <article-title>A two-dimensional probabilistic acute human-health risk assessment of insecticide exposure after adult mosquito management</article-title>. <source>Stoch. Environ. Res. Risk Assess</source>. <volume>23</volume>(<issue>5</issue>):<fpage>555</fpage>&#x02013;<lpage>563</lpage>.</mixed-citation></ref><ref id="R37"><mixed-citation publication-type="journal"><name><surname>Schleier</surname><given-names>JJ</given-names><suffix>III</suffix></name>, <name><surname>Marshall</surname><given-names>LA</given-names></name>, <name><surname>Davis</surname><given-names>RS</given-names></name>, <etal/>
<year>2015</year>. <article-title>A quantitative approach for integrating multiple lines of evidence for the evaluation of environmental health risks</article-title>. <source>PeerJ</source>
<volume>3</volume>:<fpage>e730</fpage>.<pub-id pub-id-type="pmid">25648367</pub-id>
</mixed-citation></ref><ref id="R38"><mixed-citation publication-type="journal"><name><surname>Snyder</surname><given-names>RE</given-names></name>, <name><surname>Cooksey</surname><given-names>GS</given-names></name>, <name><surname>Kramer</surname><given-names>V</given-names></name>, <etal/>
<year>2021</year>. <article-title>West Nile virus-associated hospitalizations, California, 2004&#x02013;2017</article-title>. <source>Clin. Infect. Dis</source>. <volume>73</volume>(<issue>3</issue>):<fpage>441</fpage>&#x02013;<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciaa749</pub-id><pub-id pub-id-type="pmid">32525967</pub-id>
</mixed-citation></ref><ref id="R39"><mixed-citation publication-type="journal"><name><surname>Teske</surname><given-names>ME</given-names></name>, <name><surname>Thistle</surname><given-names>HW</given-names></name>, <name><surname>Fritz</surname><given-names>BK</given-names></name>. <year>2019</year><comment>2019</comment>. <article-title>An update to AGDISP model development</article-title>. <source>Trans. ASABE</source>
<volume>62</volume>(<issue>2</issue>):<fpage>343</fpage>&#x02013;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.13031/trans.13129</pub-id></mixed-citation></ref><ref id="R40"><mixed-citation publication-type="journal"><name><surname>Tricco</surname><given-names>AC</given-names></name>, <name><surname>Lillie</surname><given-names>E</given-names></name>, <name><surname>Zarin</surname><given-names>W</given-names></name>, <etal/>
<year>2018</year>. <article-title>PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation</article-title>. <source>Ann. Intern. Med</source>. <volume>169</volume>(<issue>7</issue>):<fpage>467</fpage>&#x02013;<lpage>473</lpage>. <pub-id pub-id-type="doi">10.7326/M18-0850</pub-id><pub-id pub-id-type="pmid">30178033</pub-id>
</mixed-citation></ref><ref id="R41"><mixed-citation publication-type="journal"><name><surname>Valcke</surname><given-names>M</given-names></name>, <name><surname>Gosselin</surname><given-names>NH</given-names></name>, <name><surname>Belleville</surname><given-names>D</given-names></name>. <year>2008</year>. <article-title>Human exposure to malathion during a possible vector-control intervention against West Nile virus. II: evaluation of the toxicological risks using a probabilistic approach</article-title>. <source>Hum. Ecol. Risk Assess</source>. <volume>14</volume>(<issue>6</issue>):<fpage>1138</fpage>&#x02013;<lpage>1158</lpage>. <pub-id pub-id-type="doi">10.1080/10807030802493891</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Fig. 1.</label><caption><p id="P47">Flowchart of article selection with exclusion criteria.</p></caption><graphic xlink:href="nihms-2050953-f0001" position="float"/></fig><fig position="float" id="F2"><label>Fig. 2.</label><caption><p id="P48">Summary of risk quotients reported.</p></caption><graphic xlink:href="nihms-2050953-f0002" position="float"/></fig><table-wrap position="float" id="T1" orientation="landscape"><label>Table 1.</label><caption><p id="P49">Inclusion and exclusion criteria followed during title/abstract and full-text review screenings of eligible articles</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Criteria subgroup</th><th align="center" valign="middle" rowspan="1" colspan="1">Inclusion</th><th align="center" valign="middle" rowspan="1" colspan="1">Exclusion</th></tr><tr><th colspan="3" align="left" valign="top" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Location</td><td align="left" valign="top" rowspan="1" colspan="1">Study conducted in United States or Canada</td><td align="left" valign="top" rowspan="1" colspan="1">Studies conducted outside of United States or Canada</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Insecticide used</td><td align="left" valign="top" rowspan="1" colspan="1">Organophosphates: naled, malathion, chlorpyrifos</td><td align="left" valign="top" rowspan="1" colspan="1">Studies involving insecticides that are not organophosphates (e.g., pyrethroids, organochlorines)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Insecticide application method</td><td align="left" valign="top" rowspan="1" colspan="1">Ground or aerial spraying (e.g., ultra-low volume)</td><td align="left" valign="top" rowspan="1" colspan="1">Bed nets, indoor spraying, indoor coils</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Human health association</td><td align="left" valign="top" rowspan="1" colspan="1">Studies that report human-health effect associated with organophosphates used for adult mosquito control</td><td align="left" valign="top" rowspan="1" colspan="1">In vitro or animal studies</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Article format</td><td align="left" valign="top" rowspan="1" colspan="1">English language, published, nonsystematic &#x00026; systematic review articles included</td><td align="left" valign="top" rowspan="1" colspan="1">Presentations, white papers, grey literature, abstracts, and trade articles</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T2" orientation="landscape"><label>Table 2.</label><caption><p id="P50">Cohort studies evaluating human health effects associated with organophosphate exposure</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Study</th><th align="center" valign="bottom" rowspan="1" colspan="1">Study design</th><th align="center" valign="bottom" rowspan="1" colspan="1">Insecticide(s) &#x00026; application method(s)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Participants/population, sample size, location(s), duration</th><th align="center" valign="bottom" rowspan="1" colspan="1">Outcome &#x00026; unit of measurement</th><th align="center" valign="bottom" rowspan="1" colspan="1">Findings</th></tr><tr><th colspan="6" align="left" valign="top" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="R8" ref-type="bibr">CDC 2003</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">Cohort study (retrospective)</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Insecticide(s):</bold> Malathion, sumithrin<xref rid="TFN1" ref-type="table-fn">*</xref>, resmethrin<xref rid="TFN1" ref-type="table-fn">*</xref>; <bold>Application method(s):</bold> Ground &#x00026; aerial spraying</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Participants/population:</bold> Residents in areas that conducted spraying with national case definition for insecticide poisoning (<italic toggle="yes">n</italic> = 133); <bold>Location(s):</bold> Arizona, California, Florida, Louisiana, Michigan, New York, Oregon, Texas and Washington; Duration: April 1999-September 2002</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Outcome(s):</bold> Identified ocular, dermal, cardiovascular, renal-genitourinary, miscellaneous cases linked with exposure to insecticide use; <bold>Unit of measurement:</bold> Severity Index</td><td align="left" valign="top" rowspan="1" colspan="1">Using the Severity Index for use in State-based Surveillance of Acute Insecticide-Related Illness and Injury, malathion and naled cases were associated with illnesses of moderate to low severity.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="R9" ref-type="bibr">CDC 2005</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">Cohort study (prospective)</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Insecticide(s):</bold> Naled, permethrin<xref rid="TFN1" ref-type="table-fn">*</xref>, d-phenothrin<xref rid="TFN1" ref-type="table-fn">*</xref>; <bold>Application Method(s):</bold> ULV<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup> aerial &#x00026; ground spraying</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Participants/population:</bold> Residents randomly selected from census blocks marked for spraying. North Carolina <italic toggle="yes">n</italic> = 75, Virginia <italic toggle="yes">n</italic> = 83. <bold>Location(s):</bold> North Carolina and Virginia Duration: September 30, 2003.</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Outcomes(s):</bold> Urine sampling/testing for nonspecific organophosphate metabolite dimethylphosphate (DMP) compared to baseline; <bold>Unit of measurement:</bold> LOD DMP = 0.5 &#x003bc;g/L</td><td align="left" valign="top" rowspan="1" colspan="1">Concentrations for all pre and postspray pesticide metabolites were low. The findings did not indicate an overall increase in pesticide metabolite concentrations after mosquito control spraying events.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="R14" ref-type="bibr">Duprey et al. 2008</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">Cohort study (prospective)</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Insecticide(s):</bold> Naled; <bold>Application method(s):</bold> ULV<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup> aerial spraying</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Participants/population:</bold> Residents in the 5 proposed spray zones <italic toggle="yes">(n</italic> = 205), <bold>Location(s):</bold> St. Johns County, Florida; <bold>Duration:</bold> October 2&#x02013;7, 2004</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Outcomes(s):</bold> Urine sampling/testing for nonspecific organophosphate metabolite dimethylphosphate <bold>(DMP); Unit of measurement:</bold> LOD DMP = 0.5 &#x003bc;g/L (DMP &#x0003c; LOD = non detectable)</td><td align="left" valign="top" rowspan="1" colspan="1">Aerial application of naled for large-scale mosquito control did not contribute to detectable urinary DMP levels in the study population.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="R27" ref-type="bibr">Likos et al. 2016</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">Cohort study (prospective/ retrospective)</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Insecticide(s):</bold> Naled, sumithrin<xref rid="TFN1" ref-type="table-fn">*</xref>, prallethrin<xref rid="TFN1" ref-type="table-fn">*</xref>; Bti<xref rid="TFN1" ref-type="table-fn">*</xref><sup><xref rid="TFN4" ref-type="table-fn">c</xref></sup>
<bold>Application method(s):</bold> ULV<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup> aerial &#x00026; ground spraying</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Participants/population:</bold> Residents in 4 zip-code areas with spraying and had an insecticide-related illness and reported to poison information centers (<italic toggle="yes">n</italic> = 7) or ED<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup> visits; <bold>Location(s):</bold> Miami-Dade County, Florida; <bold>Duration:</bold> January 1, 2011-August 17, 2016</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Outcomes(s):</bold> Exposure calls from Florida Poison Information Center or identified asthma, reactive airway disease, wheezing or shortness of breath ED<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup> cases linked with exposure to insecticide use; <bold>Unit of measurement:</bold> insecticide-related illness and injury, yes/no</td><td align="left" valign="top" rowspan="1" colspan="1">The total ED<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup> patient visits in the 4 zip code areas with spraying were unchanged from number of visits before spraying. Patient visits for asthma, reactive airway disease, wheezing, or shortness of breath remained similar&#x02014;compared week-week, and during the past 2 years before spraying.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="R31" ref-type="bibr">O&#x02019;Sullivan et al. 2005</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">Cohort study (retrospective)</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Insecticide(s):</bold> Malathion, resmethrin<xref rid="TFN1" ref-type="table-fn">*</xref>; <bold>Application method(s):</bold> ULV<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup> aerial &#x00026; ground spraying</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Participants/population:</bold> Asthmatic children and adults residing in spray areas who sought outpatient and inpatient ED<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup> care (<italic toggle="yes">n</italic> = 1,318); <bold>Location(s):</bold> South Bronx, New York City, New York; <bold>Duration:</bold> August 1, 1999-September 30, 1999</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Outcomes(s):</bold> Hospital visits and hospitalization of acute exacerbation of asthma symptoms; <bold>Unit of measurement:</bold> asthma attack, yes/no</td><td align="left" valign="top" rowspan="1" colspan="1">No significant increases in hospital admissions or acute outpatient asthma care during nonspraying and spraying days in 1999 compared with ED data from 1997 and 1998</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p id="P51">Insecticides that are not organophosphates and thus excluded from analysis.</p></fn><fn id="TFN2"><label>a</label><p id="P52">Ultra-low volume.</p></fn><fn id="TFN3"><label>b</label><p id="P53">Emergency department.</p></fn><fn id="TFN4"><label>c</label><p id="P54"><italic toggle="yes">Bacillus thuringiensis</italic> subspecies <italic toggle="yes">israelensis</italic>.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3" orientation="landscape"><label>Table 3.</label><caption><p id="P55">Case study evaluating human health effects associated with organophosphate exposure</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Study</th><th align="center" valign="bottom" rowspan="1" colspan="1">Study design</th><th align="center" valign="bottom" rowspan="1" colspan="1">Insecticide(s) &#x00026; application method(s)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Participants/population, sample size, location(s), duration</th><th align="center" valign="bottom" rowspan="1" colspan="1">Outcome &#x00026; unit of measurement</th><th align="center" valign="bottom" rowspan="1" colspan="1">Findings</th></tr><tr><th colspan="6" align="left" valign="top" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="R35" ref-type="bibr">Scharf et al. 2008</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">Case study</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Insecticide(s):</bold> Malathion; <bold>Application method(s):</bold> Dermal application in laboratory setting</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Participants/population:</bold> Volunteer subjects (<italic toggle="yes">n</italic> = 20)/hands and forearms exposed to aqueous malathion solution at 50 ppb; <bold>Location(s):</bold> n/a; <bold>Duration:</bold> 30&#x02013;120 min</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Outcomes(s):</bold> Dermal absorption of malathion; <bold>Unit of measurement:</bold> Hazard Index (HI) derived from Kp-malathion (HI max = 12 mcg/kg/day)</td><td align="left" valign="top" rowspan="1" colspan="1">Exposure to aqueous malathion at concentrations expected following usual aerial applications not appreciably absorbed in test subjects.</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T4" orientation="landscape"><label>Table 4.</label><caption><p id="P56">Simulated risk assessments evaluating human health toxicological risk associated with organophosphate exposure</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Study</th><th align="center" valign="bottom" rowspan="1" colspan="1">Risk assessment method</th><th align="center" valign="bottom" rowspan="1" colspan="1">Insecticide(s), model application method(s), spray events</th><th align="center" valign="bottom" rowspan="1" colspan="1">Population model, location/ weather model</th><th align="center" valign="bottom" rowspan="1" colspan="1">Outcome(s)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Findings</th></tr><tr><th colspan="6" align="left" valign="top" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="R32" ref-type="bibr">Peterson et al. 2006</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">In silico ULV (air: AERMOD; deposition: ISCST3).</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Insecticide(s):</bold> Malathion, naled, permethrin<xref rid="TFN5" ref-type="table-fn">*</xref>, pyrethrin<xref rid="TFN5" ref-type="table-fn">*</xref>, resmethrin<xref rid="TFN5" ref-type="table-fn">*</xref>, phenothrin<xref rid="TFN5" ref-type="table-fn">*</xref>, PBO<sup><xref rid="TFN6" ref-type="table-fn">a</xref></sup><xref rid="TFN5" ref-type="table-fn">*</xref>; <bold>Model application method(s):</bold> truck mounted ULV<sup><xref rid="TFN7" ref-type="table-fn">b</xref></sup>
<bold>spraying; Spray events = 1</bold> for acute exposure; 10 for subacute exposure</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Population model:</bold> Adult males (&#x0003e; 18 yrs<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>), adult reproductive females (13&#x02013;54 yrs<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>), infants (0.5&#x02013;1.5 yrs<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>) &#x00026; children (2&#x02013;3, 5&#x02013;6, 10&#x02013;12 yrs<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>); <bold>Location/weather model:</bold> Albany, NY &#x00026; Salem, MA</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Outcomes(s):</bold> Acute &#x00026; subchronic: inhalation exposure, dermal exposure from spray deposition, hand-to-mouth exposure from spray deposition on hands, ingestion of garden produce</td><td align="left" valign="top" rowspan="1" colspan="1">Each subgroup from acute or subchronic outcomes had RQ<sup><xref rid="TFN9" ref-type="table-fn">d</xref></sup> &#x0003c; 1.0. Health risks from residential exposure to mosquito adulticides were low and not likely to exceed levels of concern.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="R36" ref-type="bibr">Schleier et al. 2009</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">In silico ULV (air: AERMOD; deposition: ISCST3)</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Insecticide(s):</bold> Malathion, Naled, phenothrin<xref rid="TFN5" ref-type="table-fn">*</xref>, resmethrin<xref rid="TFN5" ref-type="table-fn">*</xref>, PBO<sup><xref rid="TFN6" ref-type="table-fn">a</xref></sup><xref rid="TFN5" ref-type="table-fn">*</xref>, pyrethrins<xref rid="TFN5" ref-type="table-fn">*</xref>; <bold>Application method(s):</bold> truck mounted ULV<sup><xref rid="TFN7" ref-type="table-fn">b</xref></sup>; Spray events = 1 for acute exposure</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Population Model:</bold> Adult males and adult females (18&#x02013;65 yrs<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>), youth (10&#x02013;12 yrs<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>), children (5&#x02013;6 yrs<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>), toddlers (2&#x02013;3 yrs<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>), infants (0.5&#x02013;1.5 yrs<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>); <bold>Location/weather model:</bold> Albany, NY 1988</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Outcomes(s):</bold> acute inhalation, dermal, and dietary and nondietary ingestion exposure</td><td align="left" valign="top" rowspan="1" colspan="1">RQ<sup><xref rid="TFN9" ref-type="table-fn">d</xref></sup> for malathion and naled below the RQ<sup><xref rid="TFN9" ref-type="table-fn">d</xref></sup> level of concern</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="R37" ref-type="bibr">Schleier et al. 2015</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">Meta-analysis of eleven previous studies.</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Insecticide(s):</bold> Malathion, permethrin<xref rid="TFN5" ref-type="table-fn">*</xref>; <bold>Application method(s):</bold> ULV<sup><xref rid="TFN7" ref-type="table-fn">b</xref></sup>; Spray Events = n/a</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Population model</bold> Adult males; <bold>Location/weather model:</bold> n/a</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Outcomes(s):</bold> Toxicological risk</td><td align="left" valign="top" rowspan="1" colspan="1">The probability that exposure to malathion or permethrin after ULV<sup><xref rid="TFN7" ref-type="table-fn">b</xref></sup> would exceed levels of concern was less than 0.0001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="R41" ref-type="bibr">Valcke et al. 2008</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">In silico ULV (air deposition: AGDISP)</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Insecticide(s):</bold> Malathion; <bold>Application method(s):</bold> aerial and ground ULV<sup><xref rid="TFN7" ref-type="table-fn">b</xref></sup>; <bold>Spray events = 7</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Population model:</bold> Adult (&#x0003e; 19 yrs<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>), adolescents (&#x0003e; 11&#x02013;19 yrs<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>), children (&#x0003e; 4&#x02013;11 yrs<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>), toddlers (&#x0003e; 0.5&#x02013;4 yrs<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>), infants (0&#x02013;0.5 yrs<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>); <bold>Location/weather model:</bold> Quebec, Canada</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Outcomes(s):</bold> Acute and subchronic exposure to malathion after aerial spraying</td><td align="left" valign="top" rowspan="1" colspan="1">After aerial spraying RQ<sup><xref rid="TFN9" ref-type="table-fn">d</xref></sup> means were &#x0003e; 1.0 for infants (acute = 1.27; subchronic = 1.12) and toddlers (acute = 1.87; subchronic = 1.62) and children (acute = 1.05)</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><label>*</label><p id="P57">Insecticides that are not organophosphates and thus excluded from analysis in this review.</p></fn><fn id="TFN6"><label>a</label><p id="P58">Piperonyl butoxide.</p></fn><fn id="TFN7"><label>b</label><p id="P59">Ultra-low volume.</p></fn><fn id="TFN8"><label>c</label><p id="P60">Years.</p></fn><fn id="TFN9"><label>d</label><p id="P61">Risk quotient&#x02014;RQ &#x0003c; 1.0 is below level of regulatory concern (<xref rid="R18" ref-type="bibr">Environmental Protection Agency 2023b</xref>).</p></fn></table-wrap-foot></table-wrap></floats-group></article>